miR‐155 increases stemness and decitabine resistance in triple‐negative breast cancer cells by inhibiting TSPAN5-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR‐155 increases stemness and decitabine resistance in triple‐negative breast cancer cells by inhibiting TSPAN5

Published:2020-02-24 Issue:4 Volume:59 Page:447-461
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol Carcinog

Author:

Yang La‐Wei¹²^ORCID,Wu Xian‐Jin¹³^ORCID,Liang Yi¹,Ye Guang‐Qing¹,Che Yuchuan³,Wu Xue‐Zhen³,Zhu Xiao‐Jie³,Fan Huo‐Liang³,Fan Xiang‐Ping³,Xu Jun‐Fa⁴

Affiliation:

1. Clinical Research CenterAffiliated Hospital of Guangdong Medical UniversityZhanjiang China

2. Department of Pathology, School of Basic Medical SciencesSouthern Medical UniversityGuangzhou China

3. Department of Clinical LaboratoryHuizhou Municipal Central HospitalHuizhou China

4. Department of Clinical ImmunologyGuangdong Medical UniversityDongguan China

Funder

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23167

Reference42 articles.

1. Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology

2. Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors

3. The development of activatable lytic peptides for targeting triple negative breast cancer

4. Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer

5. A comparison of toxicities in acute myeloid leukemia patients with and without renal impairment treated with decitabine

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of MiR-155 Using Exosomal Delivery of Antagomir Can Up-Regulate PTEN in Triple Negative Breast Cancer;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-11

2. The Overexpressed MicroRNAs miRs-182, 155, 493, 454, and U6 snRNA and Underexpressed let-7c, miR-328, and miR-451a as Potential Biomarkers in Invasive Breast Cancer and Their Clinicopathological Significance;Oncology;2024-08-12

3. The role of miR-155 in urologic malignancies;Biomedicine & Pharmacotherapy;2024-05

4. Tspan protein family: focusing on the occurrence, progression, and treatment of cancer;Cell Death Discovery;2024-04-22

5. MicroRNA‑155‑5p inhibits trophoblast cell proliferation and invasion by disrupting centrosomal function;Molecular Medicine Reports;2024-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3